{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:16:53Z","timestamp":1787872613943,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01.HD081299"],"award-info":[{"award-number":["R01.HD081299"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bcp.2023.115867","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:15:26Z","timestamp":1697814926000},"page":"115867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers"],"prefix":"10.1016","volume":"218","author":[{"given":"Aarzoo","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Saradhi Mettu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-0912","authenticated-orcid":false,"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115867_b0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy."},{"key":"10.1016\/j.bcp.2023.115867_b0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2165\/00003088-200342140-00002","article-title":"Principles and clinical application of assessing alterations in renal elimination pathways","volume":"42","author":"Tett","year":"2003","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.bcp.2023.115867_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by Organic Anion Transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0020","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.bcp.2023.115867_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: A systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol Rev."},{"key":"10.1016\/j.bcp.2023.115867_b0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1552-4604.1990.tb03438.x","article-title":"The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers","volume":"30","author":"Inotsume","year":"1990","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/clpt.1981.208","article-title":"Kinetics and renal handling of cefonicid","volume":"30","author":"Pitkin","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0009-9236(95)90173-6","article-title":"Effect of probenecid on the distribution and elimination of ciprofloxacin in humans","volume":"58","author":"Jaehde","year":"1995","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jps.2600690526","article-title":"Preliminary evaluation of furosemide-probenecid interaction in humans","volume":"69","author":"Smith","year":"1980","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.bcp.2023.115867_b0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2125.1979.tb01032.x","article-title":"Probenecid: An unexplained effect on cephalosporin pharmacology","volume":"8","author":"Welling","year":"1979","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt196893345","article-title":"Apparent effect of probenecid on the distribution of penicillins in man","volume":"9","author":"Gibaldi","year":"1968","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI102482","article-title":"Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations","volume":"30","author":"Burnell","year":"1951","journal-title":"J Clin Invest."},{"key":"10.1016\/j.bcp.2023.115867_b0065","first-page":"692","article-title":"Verwey-van Wissen, Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide","volume":"39","author":"Vree","year":"1995","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.118.252643","article-title":"Evidence for the validity of pyridoxic acid (PDA) as a plasma-based endogenous probe for OAT1 and OAT3 function in healthy subjects","volume":"368","author":"Shen","year":"2019","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0075","first-page":"197","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Application of Moment Analysis, Eur J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-3476(83)80433-8","article-title":"Plasma and urinary kinetics of furosemide in newborn infants","volume":"103","author":"Tuck","year":"1983","journal-title":"J Pediatr."},{"key":"10.1016\/j.bcp.2023.115867_b0085","article-title":"Pharmacokinetics of orally administered furosemide","volume":"15","author":"Kelly","year":"1974","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00554663","article-title":"Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide","volume":"20","author":"Keller","year":"1981","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00561400","article-title":"Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure","volume":"12","author":"Andreasen","year":"1977","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2023.115867_b0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cpt.1516","article-title":"A comprehensive analysis of ontogeny of renal drug transporters: mRNA analyses, quantitative proteomics, and localization","volume":"106","author":"Cheung","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0105","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-019-0359-1","article-title":"Optimized renal transporter quantification by using aquaporin 1 and aquaporin 2 as anatomical markers: Application in characterizing the ontogeny of renal transporters and its correlation with hepatic transporters in paired human samples","volume":"21","author":"Li","year":"2019","journal-title":"AAPS Journal."},{"key":"10.1016\/j.bcp.2023.115867_b0110","article-title":"Reimagining the framework supporting the static analysis of transporter drug interaction risk; integrated use of biomarkers to generate pan-transporter inhibition signatures","author":"Rodrigues","year":"2022","journal-title":"Clin Pharmacol Ther."},{"issue":"5","key":"10.1016\/j.bcp.2023.115867_b0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: Perspectives from the international transporter consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0120","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40262-021-01004-2","article-title":"Clinical investigation on endogenous biomarkers to predict strong OAT-mediated drug-drug interactions","volume":"60","author":"Willemin","year":"2021","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.bcp.2023.115867_b0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/dmd.121.000486","article-title":"Endogenous plasma kynurenic acid in human: A newly discovered biomarker for drug-drug interactions involving organic anion transporter 1 and 3 inhibition","volume":"49","author":"Tang","year":"2021","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cpt.2630","article-title":"Blockade of organic anion transport in humans after treatment with the drug probenecid leads to major metabolic alterations in plasma and urine","volume":"112","author":"Granados","year":"2022","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.bcp.2023.115867_b0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.113.055475","article-title":"6\u03b2-Hydroxycortisol Is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3\/SLC22A8, in healthy subjects","volume":"42","author":"Imamura","year":"2014","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0140","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug-drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/dmd.117.077586","article-title":"Discovery and validation of pyridoxic acid and homovanillic acid as novel endogenous plasma biomarkers of organic anion transporter (OAT) 1 and OAT3 in Cynomolgus monkeys","volume":"46","author":"Shen","year":"2018","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0150","unstructured":"UniProt website. https:\/\/www.uniprot.org\/align, (n.d.)."},{"key":"10.1016\/j.bcp.2023.115867_b0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bdd.322","article-title":"Disposition of acamprosate in the rat: Influence of probenecid","volume":"23","author":"Zornoza","year":"2002","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.047","article-title":"Tubular transporters and clearance of adefovir","volume":"540","author":"Servais","year":"2006","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115867_b0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/AAC.42.2.456","article-title":"Effects of Probenecid and Cimetidine on Renal Disposition of Ofloxacin in Rats","volume":"42","author":"Foote","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2023.115867_b0170","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/dmd.119.086579","article-title":"Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics","volume":"47","author":"Basit","year":"2019","journal-title":"Drug Metabolism and Disposition."},{"key":"10.1016\/j.bcp.2023.115867_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.702","article-title":"Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions","volume":"56","author":"Feng","year":"2016","journal-title":"The Journal of Clinical Pharmacology."},{"key":"10.1016\/j.bcp.2023.115867_b0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.bcp.2023.115867_b0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"59","author":"Maeda","year":"2014","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.bcp.2023.115867_b0190","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1074\/jbc.M508050200","article-title":"Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice","volume":"281","author":"Eraly","year":"2006","journal-title":"J Biol Chem."},{"issue":"11","key":"10.1016\/j.bcp.2023.115867_b0195","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3390\/pharmaceutics14112307","article-title":"Construction and Evaluation of a Novel Organic Anion Transporter 1\/3 CRISPR\/Cas9 Double-Knockout Rat Model","volume":"14","author":"Gou","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.bcp.2023.115867_b0200","article-title":"Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.bcp.2023.115867_b0205","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1124\/dmd.113.052647","article-title":"Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways","volume":"41","author":"Wu","year":"2013","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiol Genomics."},{"key":"10.1016\/j.bcp.2023.115867_b0215","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2008020180","article-title":"Organic Anion Transporter 3 Contributes to the Regulation of Blood Pressure","volume":"19","author":"Vallon","year":"2008","journal-title":"Journal of the American Society of Nephrology."},{"key":"10.1016\/j.bcp.2023.115867_b0220","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted Metabolomics Identifies Enterobiome Metabolites and Putative Uremic Toxins as Substrates of Organic Anion Transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J Proteome Res."},{"key":"10.1016\/j.bcp.2023.115867_b0225","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160437","article-title":"The kidney drug transporter OAT1 regulates gut microbiome\u2013dependent host metabolism","volume":"8","author":"Granados","year":"2023","journal-title":"JCI Insight."},{"key":"10.1016\/j.bcp.2023.115867_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.05.007","article-title":"Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel","author":"Ma","year":"2023","journal-title":"J Pharm Anal."},{"key":"10.1016\/j.bcp.2023.115867_b0235","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/dmd.113.051409","article-title":"Minor Compensatory Changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Do Not Detract from Their Utility in the Study of Transporter-Mediated Pharmacokinetics","volume":"41","author":"Zamek-Gliszczynski","year":"2013","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2023.115867_b0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ajcn\/75.1.57","article-title":"Elevated plasma 4-pyridoxic acid in renal insufficiency","volume":"75","author":"Coburn","year":"2002","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.bcp.2023.115867_b0245","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ajcn\/32.5.1024","article-title":"The vitamin B6 requirement in oral contraceptive users II. Assessment by tryptophan metabolites, vitamin B6, and pyridoxic acid levels in urine","volume":"32","author":"Donald","year":"1979","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.bcp.2023.115867_b0250","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/ajcn\/62.5.979","article-title":"Pyridoxic acid excretion during low vitamin B-6 intake, total fasting, and bed rest","volume":"62","author":"Coburn","year":"1995","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.bcp.2023.115867_b0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\u2019-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J Clin Investig."},{"key":"10.1016\/j.bcp.2023.115867_b0260","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s11095-017-2184-5","article-title":"Investigation of glycochenodeoxycholate sulfate and chenodeoxycholate glucuronide as surrogate endogenous probes for drug interaction studies of OATP1B1 and OATP1B3 in healthy Japanese volunteers","volume":"34","author":"Takehara","year":"2017","journal-title":"Pharm Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115867_b0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/metabo8020031","article-title":"Software tools and approaches for compound identification of LC-MS\/MS data in metabolomics","volume":"8","author":"Bla\u017eenovi\u0107","year":"2018","journal-title":"Metabolites."},{"key":"10.1016\/j.bcp.2023.115867_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000353977","article-title":"Decreased Expression of a Novel Prostaglandin Transporter, OAT-PG, Facilitates Renocortical PGE2 Accumulation during Rat Pregnancy","volume":"76","author":"Kazama","year":"2013","journal-title":"Gynecol Obstet Invest."},{"key":"10.1016\/j.bcp.2023.115867_b0275","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00424-013-1351-8","article-title":"Glucocorticoid mediates the transcription of OAT-PG, a kidney-specific prostaglandin transporter","volume":"466","author":"Hatano","year":"2014","journal-title":"Pflugers Arch."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:07:07Z","timestamp":1731028027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223004586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"alternative-id":["S0006295223004586"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115867","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115867"}}